These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1474 related items for PubMed ID: 17723086

  • 21. A 16-week, randomized, double-blind, placebo-controlled, crossover trial to quantify the combined effect of an angiotensin-converting enzyme inhibitor and a beta-blocker on blood pressure reduction.
    Wald DS, Law M, Mills S, Bestwick JP, Morris JK, Wald NJ.
    Clin Ther; 2008 Nov; 30(11):2030-9. PubMed ID: 19108791
    [Abstract] [Full Text] [Related]

  • 22. Intermittent blood pressure control: potential consequences for outcome.
    Leenen FH.
    Can J Cardiol; 1999 May; 15 Suppl C():13C-18C. PubMed ID: 10380687
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Relationship between radial and central arterial pulse wave and evaluation of central aortic pressure using the radial arterial pulse wave.
    Takazawa K, Kobayashi H, Shindo N, Tanaka N, Yamashina A.
    Hypertens Res; 2007 Mar; 30(3):219-28. PubMed ID: 17510503
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Impact of statin therapy on central aortic pressures and hemodynamics: principal results of the Conduit Artery Function Evaluation-Lipid-Lowering Arm (CAFE-LLA) Study.
    Williams B, Lacy PS, Cruickshank JK, Collier D, Hughes AD, Stanton A, Thom S, Thurston H, CAFE and ASCOT Investigators.
    Circulation; 2009 Jan 06; 119(1):53-61. PubMed ID: 19103995
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. [Status of ongoing controlled clinical trials on hypertension].
    Kjeldsen SE, Syvertsen JO, Lund-Johansen P.
    Tidsskr Nor Laegeforen; 1996 Jan 10; 116(1):61-3. PubMed ID: 8553340
    [Abstract] [Full Text] [Related]

  • 33. Are we misunderstanding beta-blockers.
    Cruickshank JM.
    Int J Cardiol; 2007 Aug 09; 120(1):10-27. PubMed ID: 17433471
    [Abstract] [Full Text] [Related]

  • 34. Do ancillary properties of antihypertensive drugs explain the outcome results of recent trials?
    Staessen JA, Wang J.
    J Nephrol; 2002 Aug 09; 15(4):422-7. PubMed ID: 12243374
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Central blood pressure and hypertension: role in cardiovascular risk assessment.
    Safar ME, Jankowski P.
    Clin Sci (Lond); 2009 Feb 09; 116(4):273-82. PubMed ID: 19138169
    [Abstract] [Full Text] [Related]

  • 38. Further evidence for low-dose combinations in patients with left ventricular hypertrophy.
    Dahlöf B.
    J Hum Hypertens; 2005 Jun 09; 19 Suppl 1():S9-14. PubMed ID: 16075032
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Indices of pulse wave analysis are better predictors of left ventricular mass reduction than cuff pressure.
    Hashimoto J, Imai Y, O'Rourke MF.
    Am J Hypertens; 2007 Apr 09; 20(4):378-84. PubMed ID: 17386343
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 74.